Dossier: Parkinson's diseaseTherapy of behavioral disorders in Parkinson's disease
References (56)
- et al.
Risperidone in PD
Lancet
(1994) - et al.
Trimipramine: pharmacological reevaluation and comparison with clozapine
Neuropharmacol
(1991) Risperidone
Lancet
(1994)- et al.
Risperidone for hallucinations in L-dopa-treated PD patients
Lancet
(1994) - et al.
Risperidone: clinical safety and efficacy in schizophrenia
Psychopharmacol Bull
(1992) Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics
J Clin Psychopharmacol
(1995)- et al.
Fluoxetine and extrapyramidal side effects
Am J Psychiatry
(1989) - et al.
Clozapine: a 2-year open trial in PD patients with psychosis
Neurology
(1994) - et al.
Clozapine prevents recurrence of psychosis in Parkinson's disease
Mov Disord
(1992) - et al.
The emerging role of clozapine in the treatment of movement disorders
Mov Disord
(1997)
Clozapine for dopaniergic-induced paraphilias in Parkinson's disease
Mov Disord
(1998)
Clozapine in the treatment of psychosis in PD
Neurology
(1989)
Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open-label pilot study
Clin Neuropharmacol
(1998)
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
Neurology
(1998)
Motor and mental side effects of clozapine
J Clin Psychiatry
(1994)
Risk factors for nursing home placement in advanced Parkinson's disease
Neurology
(1993)
Early dopaminergic drug-induced hallucinations in parkinsonian patients
Neurology
(1998)
Psychiatric side effects of L-dopa in man
JAMA
(1971)
Increase of Parkinson disability after fluoxetine medication
Neurology
(1993)
Parkinsonism exacerbated by paroxetine
Neurology
(1994)
Olanzapine can worsen parkinsonism
Neurology
(1998)
Tolerability and therapeutic effect of clozapine: a retrospective investigation of 216 patients, treated with clozapine for up to 12 years
Acta Psychiatr Scand
(1985)
Clozapine-associated agranulocytosis: risk and aetiology
Br J Psychiatry
(1992)
Remoxipride in Parkinson's disease: differential response in patients with dyskinesias/fluctuations vs. psychosis
Ann Neurol
(1993)
Clozapine treatment of parkinsonism with psychosis
J Am Geriatr Soc
(1993)
Fluoxetine-induced akathisia: clinical and theoretical implications
J Clin Psychiatry
(1989)
Survey on the pharmacodynamics of the new antipsychotic risperidone
Psychopharmacol
(1994)
Melperone and clozapine: neuroendocrine effects of typical neuroleptic drugs
Acta Psychiatr Scand
(1989)
Cited by (12)
Sleep disorders in Parkinson's disease
2004, Clinical CornerstoneApproaching disturbed sleep in late Parkinson's disease: First step toward a proposal for a revised UPDRS
2001, Parkinsonism and Related DisordersRelationship between temporomandibular dysfunctions, sleep disorders, and anxiety among dentistry students
2022, Cranio - Journal of Craniomandibular PracticeMonoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
2018, Journal of Neural TransmissionSleep quality evaluation, chronotype, sleepiness and anxiety of Paralympic Brazilian athletes: Beijing 2008 paralympic games
2012, British Journal of Sports MedicineThe pharmacostrategy of treating sleep disorders in parkinsonism
2006, Sleep and Sleep Disorders: A Neuropsychopharmacological Approach
Copyright © 1999 Published by Elsevier Masson SAS